# DoW Helps NIH Advance CBRN Countermeasures

The Department of War and the National Institutes of Health have established an interagency agreement to use DoW acquisition capabilities and mechanisms—including grants and Other Transaction Authority—to help advance NIH-funded CBRN medical countermeasures, diagnostics, and protective equipment from research toward production. The agreement creates a potential pathway for industry participation, but no contract value, solicitation, timeline, or procurement contact has been announced, so it is not yet a specific bidding opportunity.

- Companies with medical countermeasure development, diagnostic, or protective-equipment manufacturing capabilities can assess how their offerings align with NIH-funded CBRN work that may move toward production through DoW mechanisms.
- The use of acquisition, grant, and Other Transaction Authority pathways may be relevant to firms experienced in defense research and development transitions; the signal does not identify a particular vehicle or planned solicitation.
- Procurement teams should distinguish this interagency framework from an active procurement: no value, schedule, or submission instructions are provided.

**Jurisdictions:** federal
**Industries:** Defense & Military, Healthcare
**Topics:** Contracting Vehicles
**Published:** October 02, 2026

### Government Entities
- Department of War (DoW)
- National Institutes of Health (NIH)
- National Institute of Allergy and Infectious Diseases (NIAID)

### Sources
- [The NIH-Pentagon deal isn’t a cash grab. It’s a rescue. - Breaking Defense](https://breakingdefense.com/2026/10/the-nih-pentagon-deal-isnt-a-cash-grab-its-a-rescue) - Breaking Defense